TriSalus Life Sciences (TLSIW) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to 1.12%.
- TriSalus Life Sciences' Return on Capital Employed rose 10200.0% to 1.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.12%, marking a year-over-year increase of 10200.0%. This contributed to the annual value of 2.57% for FY2024, which is 37500.0% up from last year.
- According to the latest figures from Q3 2025, TriSalus Life Sciences' Return on Capital Employed is 1.12%, which was up 10200.0% from 1.21% recorded in Q2 2025.
- In the past 5 years, TriSalus Life Sciences' Return on Capital Employed ranged from a high of 0.2% in Q4 2022 and a low of 8.17% during Q1 2024
- Moreover, its 4-year median value for Return on Capital Employed was 2.26% (2025), whereas its average is 2.9%.
- In the last 5 years, TriSalus Life Sciences' Return on Capital Employed tumbled by -63500bps in 2024 and then skyrocketed by 59800bps in 2025.
- Quarter analysis of 4 years shows TriSalus Life Sciences' Return on Capital Employed stood at 0.2% in 2022, then tumbled by -1793bps to 3.78% in 2023, then soared by 38bps to 2.33% in 2024, then surged by 52bps to 1.12% in 2025.
- Its Return on Capital Employed was 1.12% in Q3 2025, compared to 1.21% in Q2 2025 and 2.19% in Q1 2025.